FDA Drugs (New Approvals & NDA)Original article
Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
RegulatoryNegative
AI Analysis
Summary
The FDA sends PREA Non-Compliance letters under Section 505B(d)(1) to sponsors who have failed to submit required pediatric assessments by the final due date or failed to obtain deferral extensions.
Outcome Details
FDA sends PREA Non-Compliance letters to sponsors who failed to submit pediatric assessments by final due date or failed to seek/obtain deferral
Importance:3/10
Sentiment:
-0.30
PREAPediatricRegulatoryNon-ComplianceFDA
Read the original article
Published by FDA Drugs (New Approvals & NDA) on May 5, 2026 11:05 PM